DalsnaFinance

Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

Markets PR Newswire By PR Newswire 29 Jul 2026 11:00 1 min read
Hydreight Provides Business Update on its Peptide Healthcare Platform Following Recent FDA Advisory Committee Recommendations

VANCOUVER, BC and LAS VEGAS, July 29, 2026 /PRNewswire/ -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (FSE: SO6) (OTCQB: HYDTF), a digital health platform connecting healthcare providers, pharmacies and patients across the United States, today provided an...

VANCOUVER, BC and LAS VEGAS, July 29, 2026 /PRNewswire/ -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (FSE: SO6) (OTCQB: HYDTF), a digital health platform connecting healthcare providers, pharmacies and patients across the United States, today provided an...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.